ArticleCancers2022

Different Prognostic Values of Tumour and Nodal Response to Neoadjuvant Chemotherapy Depending on Subtypes of Inflammatory Breast Cancer, a 317 Patient-Study.

Maximilien Rogé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.